Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Cronos Australia Ltd. ( (AU:VIT) ).
Vitura Health’s Doctors on Demand telehealth service has surpassed 1 million consultations since the start of FY2024, underlining the scale and utilisation of its 24/7 virtual GP platform. The doctor network has expanded from about 200 to more than 320 practitioners, reflecting strong clinician engagement as the service gains traction in Australian primary care.
Since Vitura acquired Doctors on Demand in October 2023, revenue for the first three quarters of FY2026 has risen 54% over two years to $21.6 million, while operating expenditure fell 4%, lifting efficiency by 14%. This combination of record revenue growth and cost discipline has shifted the business from a negative 3% to a 5% EBITDA margin, making it a profitable, increasingly important contributor to Vitura’s revenue diversification as telehealth adoption accelerates.
More about Cronos Australia Ltd.
Vitura Health Limited is an ASX-listed diversified digital health business operating telehealth and medical technology platforms in Australia. Through subsidiaries including Doctors on Demand and the Canview ecosystem, it connects doctors, patients, pharmacies, and suppliers, focusing on virtual primary care and distribution of therapeutic products and devices across the Australian healthcare market.
Average Trading Volume: 372,882
Technical Sentiment Signal: Sell
Current Market Cap: A$24.52M
Learn more about VIT stock on TipRanks’ Stock Analysis page.